Breakthroughs Blog

City of Hope has so many breakthroughs in cancer, diabetes and HIV/AIDS - and so many stories - that we've tailored our blog, Breakthroughs, to provide something for every reader. Whether the breakthroughs are about medical research, treatment advances or personal triumphs, they're all connected.

Xiuli Wang, CAR T for multiple myeloma | City of Hope
Meet the CAR T Team: Xiuli Wang, Ph.D.

January 4, 2018 | Maxine Nunes

Xiuli Wang, Ph.D., is at the forefront of one of the most exciting breakthroughs in cancer treatment, chimeric antigen receptor (CAR) T cell therapy.

Continue Reading

Simon Bray Multiple Myeloma | City of Hope
Simon Bray: Beating the Odds

October 2, 2017 | Abe Rosenberg

Simon Bray had been ignoring a chronic backache for months until one day in the gym, he fractured a vertebra. Puzzled by the unusual workout injury, doctors ran a bunch of tests, which revealed multiple myeloma.

Continue Reading

Myeloma Series CAR T Wang homepage image
CAR T Cell Trial for Multiple Myeloma to Launch in 2017

March 22, 2017 | Travis Marshall

CAR T cell therapy research at City of Hope is an innovative and promising approach that recruits the body’s own immune system in the fight against some of the hardest-to-treat cancers, including multiple myeloma.

Continue Reading

Myeloma Series Part 2 McNutt Seated
‘Dwindling’ ribs, failing kidneys: How one woman climbed back from myeloma

March 21, 2017 | Stephanie Smith

Hypercalcemia (high blood calcium), renal problems, anemia and bone problems, also known by the acronym, C.R.A.B. — reflects the typical symptoms of multiple myeloma. City of Hope follows a multiple myeloma patient, Donna McNutt, who finds ways to cope with her diagnosis.

Continue Reading

Myeloma Series _ Cangin_White BG
'I had this monster that was in me': Coping with fear of relapse

March 20, 2017 | Stephanie Smith

Relapse is one of the most common fears among cancer patients. Nearly 60 percent of cancer survivors are moderately-to-severely concerned about recurrence one year after remission, according to data from the American Cancer Society. City of Hope follows a multiple myeloma patient, Donna McNutt, who finds ways to cope with her fear and anxiety.

Continue Reading

breakthroughs - ASH
ASH 2016: Groundbreaking new trials show promise for lymphoma and multiple myeloma patients

December 7, 2016 | City of Hope

Numerous clinical trials, which lay the groundwork for novel approaches to lymphoma and multiple myeloma therapies, could ultimately lead to new treatments that improve survival and quality of life for patients with those and other diseases. Additional studies give new insight into best practices for the treatment of various blood cancers.

Continue Reading

Donna McNutt
‘Cancer Fashionista’ dresses up to face myeloma

July 15, 2016 | Stephanie Smith

Appearance and emotions are often intertwined, so it stands to reason that improving what’s going on outwardly could help a patient - at least emotionally - face what’s going on inside with cancer. City of Hope patient Donna McNutt offers tips.

Continue Reading

Breakthroughs - ASCO
Breakthroughs in cancer research to be presented at ASCO

June 1, 2016 | Denise Heady

Members of City of Hope’s medical oncology team are part of a core group of medical professionals trying to find more ways to treat and eradicate cancer. At the 2016 ASCO meeting, they will share findings about a number of cancers and treatment approaches, including assessments of potential new therapies and comparisons of current therapies.

Continue Reading

Breakthroughs - Bob Dickey - CURE Magazine
Reaching new peaks: Multiple myeloma patient Bob Dickey honored by CURE Magazine

April 1, 2016 | City of Hope

When Bob Dickey was first diagnosed with multiple myeloma in 2010, he had no idea his cancer journey would lead him to the top of some of the highest mountain peaks in the world—From Mt. Whitney, to Mt. Kilimanjaro – nor that it would bring him to a national stage in Florida, where he was recently honored by CURE Magazine for his efforts in raising funding for multiple myeloma research.

Continue Reading

Load More
Back To Top